---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-001664"
form_type: "8-K"
ticker: "CNSP"
cik: "0001729427"
company_name: "CNS Pharmaceuticals, Inc."
filed_at: "2026-03-11T23:59:59+00:00"
generated_at: "2026-05-15T14:52:59.966607+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# CNS Pharmaceuticals posts routine investor presentation; no material new disclosures

## Summary
- Company filed Form 8-K indicating it posted a March 2026 investor presentation on its website.
- Presentation is available under Exhibits but contains no specific financial or operational updates in the filing.
- No earnings, guidance, or material events were disclosed in the presentation text provided.

## SEC filing metadata
- accession: 0001683168-26-001664
- form_type: 8-K
- ticker: CNSP
- cik: 0001729427
- company_name: CNS Pharmaceuticals, Inc.
- filed_at: 2026-03-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729427/000168316826001664/0001683168-26-001664-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729427/000168316826001664/cns_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-001664
- JSON: https://secwatch.observer/filing/0001683168-26-001664.json
- Plain text: https://secwatch.observer/filing/0001683168-26-001664.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.